| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $243.9M | — |
| R&D Expense | $129.6M | -25.3% |
| SG&A Expense | $46.8M | +15.0% |
| Operating Income | $67.6M | +132.0% |
| Pre-tax Income | $91.9M | +149.1% |
| Income Tax | $4.9M | +1527.7% |
| Net Income | $87.0M | +146.4% |
| EPS (Basic) | $2.34 | +146.8% |
| EPS (Diluted) | $2.30 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $287.4M | -48.7% |
| Accounts Receivable | $3.6M | +30.1% |
| Current Assets | $315.4M | -46.4% |
| Total Assets | $338.0M | -45.1% |
| Current Liabilities | $20.4M | -25.6% |
| Total Liabilities | $34.9M | -21.3% |
| Stockholders' Equity | $303.1M | -47.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $107.5M | +166.8% |
| Capital Expenditures | $1.6M | -19.7% |
| Investing Cash Flow | -$1.6M | +19.7% |
| Financing Cash Flow | -$378.5M | -196.6% |
| Free Cash Flow | $106.0M | +165.1% |
| +146.0% |